TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
8.70
-0.26 (-2.90%)
At close: Apr 7, 2026, 4:00 PM EDT
8.66
-0.04 (-0.46%)
After-hours: Apr 7, 2026, 6:22 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $7.98 million as of April 7, 2026. Its market cap has increased by 1,388.04% in one year.
Market Cap
7.98M
Enterprise Value
5.14M
1-Year Change
1,388.04%
Ranking
Category
Stock Price
$8.70
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $7.98M, a decrease of -83.33%. That is a compound annual growth rate of -31.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 7.98M | 27.38% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 8.24M |
| Aprea Therapeutics | 8.19M |
| Evogene | 8.11M |
| GridAI Technologies | 8.03M |
| Liminatus Pharma | 7.85M |
| Kiora Pharmaceuticals | 7.66M |
| CollPlant Biotechnologies | 7.63M |
| Creative Medical Technology Holdings | 7.59M |